UZ Gent - Dienst Neurologie
Ghent, 9000, Belgium
NCT Number: NCT05204316
The research collects spoken descriptions of headache disorders by participants with headache disorders. The speech recordings are analyzed by natural language processing (NLP) tools to analyse linguistic properties of the texts and to obtain insight into the potential of NLP machine learning models for the recognition of headache syndromes of the participants.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ghent, 9000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Recordings will be transcribed manually to written digital text formats, on which NLP tools such as tokenisation and lexical analysis will be performed.
Time frame: through study completion, an average of 1 year
Descriptive linguistic analysis of lexical choices, sentence formation and thematic content within the texts
Time frame: through study completion, an average of 1 year
To investigate the potential and learn insights of machine learning modelling to classify headache disorders based on the descriptions by participants
Time frame: through study completion, an average of 1 year
To investigate the potential and learn insights of machine learning modelling to estimate headache impact scores from different validated questionnaires investigating burden of disease and quality of life
University Hospital, Ghent
Other
Acronym: NLPH SPEECH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04936321
Brain Diseases, Central Nervous System Diseases
Seattle, Washington, United States
View Trial DetailsNCT06894121
Brain Diseases, Central Nervous System Diseases
Ankara, Cankaya, Turkey (Türkiye)
View Trial DetailsNCT07411820
Brain Diseases, Central Nervous System Diseases
Minya, Menia Governorate, Egypt
View Trial DetailsNCT07180043
Brain Diseases, Central Nervous System Diseases
Kayseri, Turkey (Türkiye)
View Trial Details